Echo IQ Lodges US FDA Application for EchoSolv Market Clearance; Shares Fall 4%
Medical technology company Echo IQ (ASX:EIQ) submitted its US Food and Drug Administration application for market clearance of EchoSolv AS, its artificial intelligence-powered decision support tool to
Echo IQ CEO Steps Down; Chairman Named Interim Successor
Echo IQ (ASX:EIQ) Chief Executive Officer Kimber Rothwell has stepped down, effective immediately, according to a Tuesday filing with the Australian Securities Exchange. Chairman Andrew Grover will su
Echo IQ Secures R&D Tax Rebate for Fiscal Year 2023
Echo IQ (ASX:EIQ) secured a AU$1.3 million rebate from the Australian government's research and development tax incentive scheme for the fiscal year ended June 30, 2023, according to a filing with the
Respiri Signs Deal to Integrate Echo IQ's Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%
Respiri (ASX:RSH) signed an exclusive licensing deal to integrate Echo IQ's (ASX: EIQ) cardiovascular diagnostic analysis technology, EchoSolv, into its remote patient monitoring system in the US, acc
Echo IQ Appoints CEO
AI and medical technology company Echo IQ (ASX:EIQ) named Kimber Rothwell as its new chief executive officer, effective Jan. 29. Rothwell has extensive experience in healthcare technology, according t
EchoIQ Applies for Patent for Heart Failure Algorithm
EchoIQ (ASX:EIQ) applied for a new provisional patent for proprietary Heart Failure algorithm. The algorithm will be incorporated into its EchoSolv program. The Australian operator of software that di
We Think Echo IQ (ASX:EIQ) Needs To Drive Business Growth Carefully
Echo IQ Secures R&D Tax Rebate for Fiscal Year 2022; Shares Fall 3%
Echo IQ (ASX:EIQ) secured a tax rebate worth AU$667,146 for the fiscal year ended June 30, 2022, under the Australian government's research and development incentive scheme. The scheme aims to encoura
Echo IQ Signs Deal to Pilot Heart Disease Detection Tool; Shares Jump 7%
Echo IQ (ASX:EIQ) signed a deal with cardiology services provider Advara HeartCare to conduct a paid pilot program for the heart disease detection tool EchoSolv in Western Australia. The program aims
Echo IQ to Launch Six Modules for Cardiology Platform
Echo IQ (ASX:EIQ) is set to launch six new modules to help support the decision-making process of cardiologists using the EchoSolv platform, the medical technology firm said on Monday. These include m
Echo IQ Completes Enrollment for Clinical Decision Software Study in the US
Echo IQ (ASX:EIQ) completed the enrollment phase of its ongoing reader study in the US investigating the performance and accuracy of its artificial-intelligence-powered clinical decision support softw
No Data